Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
PREM14A

A preliminary proxy statement relating to a merger or acquisition

Mergers & Acquisitions
DEFM14A

Definitive proxy statement relating to merger or acquisition

Mergers & Acquisitions
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
8-K

Report of unscheduled material events or corporate event

Current Reports